Improving Outcomes in Advanced RCC: Translating Evidence to Clinical Practice

A discussion on recent advances in the treatment of advanced renal cell carcinoma and their impact on clinical practice, illustrated by real-world patient profiles.

EP. 11: Advanced Renal Cell Carcinoma: Clinical Practice Pearls

April 4th 2022

Drs Sumeet Bhatia and Eric Jonasch highlight unmet needs in advanced renal cell carcinoma and share clinical pearls.

EP. 12: Patient Profile Presentation: A 58-Year-Old Woman Presenting with Gross Hematuria

April 5th 2022

Arnab Basu, MD, presents the patient profile of a 58-year-old woman with advanced renal cell carcinoma presenting with gross hematuria.

EP. 13: First-Line IO-TKI Combination Treatment Regimens for Advanced RCC

April 5th 2022

A review of the first-line IO/TKI combination regimens available for advanced RCC and the factors considered in choosing an appropriate treatment.

EP. 14: Selecting RCC Patients with Lenvatinib + Pembrolizumab Therapy and Appropriate Dosing Strategies

April 19th 2022

Oncologists discuss which patients with advanced RCC might be most suitable for treatment with lenvatinib + pembrolizumab and the appropriate dosing strategies for this regimen.

EP. 15: Adverse Events with IO-TKI Combination Regimens for Advanced RCC and Their Management

April 19th 2022

Experts review adverse events commonly observed with IO/TKI combination regimens in patients with RCC and how these are managed in clinical practice.

EP. 16: Duration of Treatment with IO-TKI Regimens and Treatment Options at Progression

April 19th 2022

Drs Anakwah and Basu share their thoughts on the duration of treatment with I/O–TKI regimens and what treatment options are available for patients at progression of renal cell carcinoma.

EP. 17: Patient Profile Presentation: A 48-Year-Old Man Presenting with a Right Renal Mass

April 19th 2022

Shawnta Anakwah, MD, presents the patient profile of a 48-year-old man with advanced renal cell carcinoma presenting with a right renal mass.

EP. 18: Approved First-Line IO-IO Combination Treatment Regimens for Advanced RCC

May 2nd 2022

A review of the first-line IO/IO combination regimens available for advanced RCC.

EP. 19: Adverse Events in IO-IO Combination Treatment Regimens for Advanced RCC

May 2nd 2022

Key opinion leaders discuss the common adverse events seen with IO/IO combination regimens and how to treat patients with brain metastases.

EP. 20: Patient Profile Presentation: A 72-Year-Old Man Presenting with Hematuria

May 4th 2022

Dr Shawnta Anakwah presents the patient profile of a 72-year-old man with advanced renal cell carcinoma presenting with hematuria.